(WASHINGTON) -- The U.S. Food and Drug Administration has approved the first drug to help prevent premature birth in women who have had at least one previous preterm delivery.
"The most common risk factor for preterm birth is recurrence," said Dr. Alan Fleischman, March of Dimes senior vice president and medical director. "This is the first approved drug to prevet recurrence for women who have had a singleton preterm baby and now have a singleton baby," he added.
Makena, expected to reduce the risk of premature births, will in turn, lower the risk of infant complications at delivery, lifelong disabilities such as cerebral palsy and death.
Preterm birth affects one in eight babies born in the United States, according to the March of Dimes.
Copyright 2011 ABC News Radio